Abstract
The prognostic value of body mass index (BMI) in metastatic breast cancer (MBC) has not been fully elucidated. In a prospective study to investigate the chemo-sensitizing effect of statins on clinical outcomes in MBC patients who were scheduled to receive palliative chemotherapy (Carboplatin and Vinorelbine), we sought to investigate the relationship between baseline BMI and clinical outcomes; response, overall survival (OS) and progression free survival (PFS), over a median follow-up of 40-months. Eighty-Two MBC patients were enrolled and categorized using baseline BMI as underweight (BMI, < 18.5 kg/m2, n = 1), normal-weight (BMI, 18.5-24.9 kg/m2, n = 20), overweight (BMI, 25-29.9 kg/m2, n = 34), and obese (BMI, ≥ 30 kg/m2, n = 27). Median OS was 10 months in normal/underweight, 19 months in overweight, and 16 months in obese (P = 0.083). Univariate Cox model revealed that overweight patients were significantly less likely to die of MBC as normal BMI patients (hazard ratio [HR] = 0.54, 95% confidence interval [CI], (0.29-0.98), P = 0.044). Similarly, multivariate Cox model, after adjusting for age, number of metastatic sites, chemotherapy line's grade, HER2 and hormone receptors status, confirmed longer survivorship of overwei...Continue Reading
References
Sep 11, 2001·Cancer·J R DalingP L Porter
May 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G BerclazUNKNOWN International Breast Cancer Study Group
Aug 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Maura K WhitemanPolly A Marchbanks
Jun 15, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Kamyar Kalantar-ZadehJohn E Morley
Sep 18, 2007·The Journal of Urology·R Bruce MontgomeryUNKNOWN Southwest Oncology Group
Aug 20, 2008·International Journal of Cancer. Journal International Du Cancer·Luigino Dal MasoUNKNOWN Prospective Analysis of Case-control studies on Environmental factors and health (PACE) study group
May 29, 2010·The Oncologist·Kathleen Y WolinGraham A Colditz
Dec 1, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marianne EwertzSøren Cold
Dec 1, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank A Sinicrope, Andrew J Dannenberg
Aug 2, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lieke H J SimkensCornelis J A Punt
Nov 1, 2011·Cancer Causes & Control : CCC·Su Yon JungJoel L Weissfeld
Feb 2, 2012·International Journal of Breast Cancer·A von DrygalskiE D Ball
Mar 27, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa MartinVickie E Baracos
Aug 10, 2013·Obesity·Katherine M Flegal, Kamyar Kalantar-Zadeh
Aug 16, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alessandra GennariPaolo Bruzzi
Nov 29, 2013·Journal of the National Cancer Institute·A Ari HakimiPaul Russo
Apr 29, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D S M ChanT Norat
Dec 22, 2016·Breast Cancer Research and Treatment·Wendie D den BrokCaroline A Lohrisch
Mar 23, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CardosoE Winer
Citations
Oct 11, 2019·Intestinal research·Duk Hwan Kim
Aug 5, 2020·Nutrition and Cancer·Aysegul SakinSener Cihan
Dec 12, 2020·The Breast : Official Journal of the European Society of Mastology·Khalil SalehElise Deluche
Feb 19, 2021·Frontiers in Immunology·Ainhoa Arana EcharriJames E Turner
Mar 24, 2021·NPJ Breast Cancer·Natansh D ModiAshley M Hopkins
Mar 30, 2021·JAMA Network Open·Fausto PetrelliAlberto Zaniboni